David C. Kaslow

Research interests

Publications

• Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response

  Vaccine · 2019 · 10.1016/j.vaccine.2019.01.011

• The Path to Group A Streptococcus Vaccines: World Health Organization Research and Development Technology Roadmap and Preferred Product Characteristics

  Clinical Infectious Diseases · 2019 · https://doi.org/10.1093/cid/ciy1143

• malERA: An updated research agenda for malaria elimination and eradication

  PLoS Medicine · 2017 · 10.1371/journal.pmed.1002456

• Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children

  New England Journal of Medicine · 2016 · 10.1056/nejmoa1515257

• Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study

  The Journal of Infectious Diseases · 2016 · 10.1093/infdis/jiw237

• WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015

  Vaccine · 2015 · 10.1016/j.vaccine.2015.05.093

• A DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccine Encoding Thrombospondin-Related Adhesion Protein but Not Circumsporozoite Protein Partially Protects Healthy Malaria-Naive Adults against Plasmodium falciparum Sporozoite Challenge

  Infection and Immunity · 2006 · 10.1128/iai.00590-06

• Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

  Nature · 2002 · https://doi.org/10.1038/415331a

• Shotgun DNA microarrays and stage‐specific gene expression in Plasmodium falciparum malaria

  Molecular Microbiology · 2000 · 10.1046/j.1365-2958.2000.01730.x

• Antibodies to Malaria Vaccine Candidates Pvs25 and Pvs28 Completely Block the Ability ofPlasmodium vivaxTo Infect Mosquitoes

  Infection and Immunity · 2000 · https://doi.org/10.1128/iai.68.12.6618-6623.2000

• A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia.

  American Journal of Tropical Medicine and Hygiene · 1998 · 10.4269/ajtmh.1998.58.211

• Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC‐Pf7, a Pox‐Vectored, Multiantigen, Multistage Vaccine Candidate forPlasmodium falciparumMalaria

  The Journal of Infectious Diseases · 1998 · 10.1086/515331

• A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines

  Infection and Immunity · 1997 · 10.1128/iai.65.3.1109-1113.1997

• Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells

  The Journal of Immunology · 1997 · 10.4049/jimmunol.159.7.3400

• Clinical Immunity to Plasmodium falciparum Malaria Is Associated with Serum Antibodies to the 19-kDa C-Terminal Fragment of the Merozoite Surface Antigen, PfMSP-l

  The Journal of Infectious Diseases · 1996 · 10.1093/infdis/173.3.765

• Immunogenicity and In Vivo Efficacy of Recombinant Plasmodium falciparum Merozoite Surface Protein-1 in Aotus Monkeys

  Molecular Medicine · 1995 · 10.1007/bf03401557

• Transmission-blocking activity of a chitinase inhibitor and activation of malarial parasite chitinase by mosquito protease.

  Proceedings of the National Academy of Sciences · 1993 · 10.1073/pnas.90.9.4266

• A family of erythrocyte binding proteins of malaria parasites.

  Proceedings of the National Academy of Sciences · 1992 · 10.1073/pnas.89.15.7085

• Cloning of the Plasmodium vivax Duffy receptor

  Molecular and Biochemical Parasitology · 1991 · 10.1016/0166-6851(91)90228-x

• Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals.

  The Journal of Experimental Medicine · 1991 · https://doi.org/10.1084/jem.174.5.1203

• Effects of magainins and cecropins on the sporogonic development of malaria parasites in mosquitoes

  Infection and Immunity · 1989 · 10.1128/iai.57.9.2628-2633.1989

• A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains

  Nature · 1988 · 10.1038/333074a0

• DNA methylation stabilizes X chromosome inactivation in eutherians but not in marsupials: evidence for multistep maintenance of mammalian X dosage compensation.

  Proceedings of the National Academy of Sciences · 1987 · 10.1073/pnas.84.17.6210

Current projects

No projects listed.